416 related articles for article (PubMed ID: 36168632)
1. Targeted delivery of nanomedicines for promoting vascular regeneration in ischemic diseases.
Zhuang J; Zhang X; Liu Q; Zhu M; Huang X
Theranostics; 2022; 12(14):6223-6241. PubMed ID: 36168632
[TBL] [Abstract][Full Text] [Related]
2. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
3. Tumor vasculature-targeting nanomedicines.
Zhang Y; He J
Acta Biomater; 2021 Oct; 134():1-12. PubMed ID: 34271167
[TBL] [Abstract][Full Text] [Related]
4. Modulating tumor mechanics with nanomedicine for cancer therapy.
Zhao Q; Chen J; Zhang Z; Xiao C; Zeng H; Xu C; Yang X; Li Z
Biomater Sci; 2023 Jun; 11(13):4471-4489. PubMed ID: 37221958
[TBL] [Abstract][Full Text] [Related]
5. Targeted nanomedicines for the treatment of bone disease and regeneration.
Ordikhani F; Zandi N; Mazaheri M; Luther GA; Ghovvati M; Akbarzadeh A; Annabi N
Med Res Rev; 2021 May; 41(3):1221-1254. PubMed ID: 33347711
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Approaches of Dual-targeted Nanomedicines for Tumor Multidrug Resistance.
Han W; Shen Z; Zou J; Ye Q; Ge C; Zhao Y; Wang T; Chen Y
Curr Drug Deliv; 2024; 21(2):155-167. PubMed ID: 37143266
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: A review.
Chen W; Jiang L; Hu Y; Fang G; Yang B; Li J; Liang N; Wu L; Hussain Z
J Control Release; 2021 Dec; 340():342-360. PubMed ID: 34695522
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers.
Tan KX; Pan S; Jeevanandam J; Danquah MK
Int J Pharm; 2019 Mar; 558():413-425. PubMed ID: 30660748
[TBL] [Abstract][Full Text] [Related]
9. Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy.
Zhou Q; Dong C; Fan W; Jiang H; Xiang J; Qiu N; Piao Y; Xie T; Luo Y; Li Z; Liu F; Shen Y
Biomaterials; 2020 May; 240():119902. PubMed ID: 32105817
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicines Targeting the Tumor Microenvironment.
Tong R; Langer R
Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
[TBL] [Abstract][Full Text] [Related]
11. Design of smart nanomedicines for effective cancer treatment.
Heshmati Aghda N; Dabbaghianamiri M; Tunnell JW; Betancourt T
Int J Pharm; 2022 Jun; 621():121791. PubMed ID: 35525473
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeted nanomedicines for cancer theranostics.
Arranja AG; Pathak V; Lammers T; Shi Y
Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
[TBL] [Abstract][Full Text] [Related]
13. Engineered nanomedicines for tumor vasculature blockade therapy.
Zhao D; Huang X; Zhang Z; Ding J; Cui Y; Chen X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1691. PubMed ID: 33480163
[TBL] [Abstract][Full Text] [Related]
14. Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment.
David A
Adv Drug Deliv Rev; 2017 Sep; 119():120-142. PubMed ID: 28506743
[TBL] [Abstract][Full Text] [Related]
15. Bioresponsive nanomedicines based on dynamic covalent bonds.
Xin X; Zhang Z; Zhang X; Chen J; Lin X; Sun P; Liu X
Nanoscale; 2021 Jul; 13(27):11712-11733. PubMed ID: 34227639
[TBL] [Abstract][Full Text] [Related]
16. Barrier permeation and improved nanomedicine delivery in tumor microenvironments.
Liu J; Zhang J; Gao Y; Jiang Y; Guan Z; Xie Y; Hu J; Chen J
Cancer Lett; 2023 May; 562():216166. PubMed ID: 37028698
[TBL] [Abstract][Full Text] [Related]
17. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics.
Overchuk M; Zheng G
Biomaterials; 2018 Feb; 156():217-237. PubMed ID: 29207323
[TBL] [Abstract][Full Text] [Related]
18. Enhancing Tumor Penetration of Nanomedicines.
Sun Q; Ojha T; Kiessling F; Lammers T; Shi Y
Biomacromolecules; 2017 May; 18(5):1449-1459. PubMed ID: 28328191
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Targeted Tumor Chemotherapy Based on Smart Nanomedicines.
Qin SY; Zhang AQ; Zhang XZ
Small; 2018 Nov; 14(45):e1802417. PubMed ID: 30247806
[TBL] [Abstract][Full Text] [Related]
20. Current understandings and clinical translation of nanomedicines for breast cancer therapy.
Jiang Y; Jiang Z; Wang M; Ma L
Adv Drug Deliv Rev; 2022 Jan; 180():114034. PubMed ID: 34736986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
